| abstract |
Provided are a compound represented by general formula (I), or a tautomer, mesomer, racemate, enantiomer, diastereomer or mixture thereof, a deuterium isotopic derivative, pharmaceutically acceptable hydrate, solvate, salt, or eutectic thereof, a pharmaceutical composition thereof, and an application thereof in preparing a medicament for lysine specific demethylase 1 inhibitor-related diseases. |